JG
ONSIZ

Jefferies Group’s Oncobiologics, Inc. Series B Warrant ONSIZ Stock Holding History

Jefferies Group’s Portfolio ONSIZ Stock Details ONSIZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-79,347
Closed -$63K – 2816
2016
Q4 		$63K Hold
79,347
– – ﹤0.01% 2072
2016
Q3 		$79K Hold
79,347
– – ﹤0.01% 2057
2016
Q2 		$36K Buy
+79,347
New +$41.7K ﹤0.01% 2009

Other funds holding ONSIZ

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jefferies Group's ONSIZ Position: Q1 2017 in Review

Jefferies Group sold out of Oncobiologics, Inc. Series B Warrant (ONSIZ) in Q1 2017, closing a stake of 79,347 shares — an estimated $63K sold.

Jefferies Group first reported a position in ONSIZ in Q2 2016 and held it in 3 quarters. The position peaked at $79K in Q3 2016. 10 funds tracked by Wall St. Rank hold ONSIZ as of Q1 2017.

  • Jefferies Group reported no remaining Oncobiologics, Inc. Series B Warrant position as of Q1 2017 after selling out during the quarter.
  • Jefferies Group sold 79,347 Oncobiologics, Inc. Series B Warrant shares in Q1 2017, an estimated $63K.
  • Jefferies Group first reported a position in Oncobiologics, Inc. Series B Warrant in Q2 2016 and held it in 3 quarters.
  • Jefferies Group's Oncobiologics, Inc. Series B Warrant position peaked at $79K in Q3 2016.
  • 10 funds tracked by Wall St. Rank held Oncobiologics, Inc. Series B Warrant as of Q1 2017.

Based on Jefferies Group's 13F filing for Q1 2017, filed 15 May 2017.